PCLAF and liver disorder: Subgroup analysis of mRNA revealed that by comparing the superiority index, KIAA0101 mRNA and GPC-3 mRNA emerged as the optimal diagnostic biomarkers for distinguishing HCC from healthy individuals and liver disease patients, respectively.